3rd Quarter - Report

OTSUKA AMERICA PHARMACEUTICAL, INC. for OTSUKA AMERICA PHARMACEUTICAL, INC.

Firm
Client
Income
—
Expenses
$80,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

Opioid Package

LobbyistCovered position, as disclosed
ORKIDEH MALKOC —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

PKD (Polycystic Kidney Disease) Awareness, Opioid Package, S. 1850 (Protecting Jessica Grubb's Legacy Act), H.R. 3545 (Overdose Prevention and Patient Safety Act) and Veteran Affairs Issues

LobbyistCovered position, as disclosed
ORKIDEH MALKOC —
MOLLY RYAN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 1850 (115th), H.R. 3545 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.